The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 349:2068-2071 November 20, 2003 Number 21
NextNext

Bisphosphonates in Children with Bone Diseases

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Marini, J. C.
-Related Article
by Whyte, M. P.
-PubMed Citation
To the Editor: In her Perspective article on bisphosphonates in children with bone diseases (July 31 issue),1 Dr. Marini comments that "treatment with bisphosphonates from infancy does not relieve the short stature of children with osteogenesis imperfecta." It is important to note that the use of bisphosphonates for the treatment of infants with osteogenesis imperfecta has only recently been attempted,2 and the patients who have been treated have not yet reached their final height. Thus, it is not feasible to predict the final effects of the treatment. In the meantime, bisphosphonate-treated children with osteogenesis imperfecta appear to be growing faster . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.